Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 1.86% is 56% below its 5-year average of 4.19%, near the high end of its 5-year range (-61.68%–14.42%).
42.94% below its 12-month average of 3.26%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -0.21%.
OPERATING MARGIN
1.86%
OPERATING MARGIN AVG TTM
3.26%
OPERATING MARGIN AVG 3Y
2.17%
OPERATING MARGIN AVG 5Y
4.19%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-42.94%
CURRENT VS 3Y AVG
-14.09%
CURRENT VS 5Y AVG
-55.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$1.52B
Operating Margin
0.09%
TTM Avg
-3.29%
3Y Avg
-12.30%
5Y Avg
-11595.24%
Market Cap
$1.65B
Operating Margin
-5.55%
TTM Avg
-16.51%
3Y Avg
-27.71%
5Y Avg
-34.02%
Market Cap
$1.65B
Operating Margin
15.35%
TTM Avg
4.65%
3Y Avg
1.95%
5Y Avg
-3.05%
Market Cap
$1.46B
Operating Margin
20.42%
TTM Avg
-52.76%
3Y Avg
-545.80%
5Y Avg
-384.16%
Market Cap
$1.43B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.71B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.57B | 1.86% | 3.26% | 2.17% | 4.19% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.09% | -3.29% | -12.30% | -11595.24% |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | 0.00% | 0.00% | 0.00% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -5.55% | -16.51% | -27.71% | -34.02% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 15.35% | 4.65% | 1.95% | -3.05% |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 20.42% | -52.76% | -545.80% | -384.16% |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 11.69% | -8.16% | -10.59% | -4.68% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 1.20% | -1.69% | -4.84% | -5.86% |
Gross Margin
58.3%
Operating Margin
1.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -0.21% |
| 2026-03-31 | 3.69% |
| 2025-12-31 | 0.81% |
| 2025-09-30 | 2.87% |
| 2025-06-30 | 9.13% |
| 2025-03-31 | 7.19% |
| 2024-12-31 | 5.98% |
| 2024-09-30 | 2.74% |
| 2024-06-30 | -9.69% |
| 2024-03-31 | -1.33% |
| 2023-12-31 | -9.62% |
| 2023-09-30 | -61.68% |
| 2023-06-30 | 14.42% |
| 2023-03-31 | 8.24% |
| 2022-12-31 | 13.14% |
| 2022-09-30 | 12.82% |
| 2022-06-30 | 5.01% |
| 2022-03-31 | 7.52% |
| 2021-12-31 | 4.57% |
| 2021-09-30 | -1.03% |
| 2021-06-30 | 7.52% |
| 2021-03-31 | 8.43% |
| 2020-12-31 | -82.80% |
| 2020-09-30 | 12.43% |
| 2020-06-30 | 22.26% |
| 2020-03-31 | 13.93% |
| 2019-12-31 | 7.52% |
| 2019-09-30 | 15.01% |
| 2019-06-30 | 10.02% |
| 2019-03-31 | 10.02% |
